High expression levels of ATP7A, CDKN2A, DLAT, DLD, DLST, GCSH, GLS, LIPT1, MTF1, PDHA1, and PDHB are the risk factors for HCC patients (Figures 3(a) and 3(b)). This evidence concerns the gene LIPT1 and hepatocellular carcinoma.